A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma

Our discovery of FN1 as a biomarker for the late-stage diagnosis of NPC will assist in clinical treatment decisions and improve the prognosis of patients.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-04-01
DOI
https://doi.org/10.1186/s12885-025-13958-8
Citations
1
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma

Yueyin Pan, Shan Xing, Qian‐Ying Zhu, Qi Huang
1 citations
BMC Cancer
Peptidase Inhibition and Analysis
1.05
article

A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma

Yueyin Pan, Shan Xing, Qian‐Ying Zhu, Qi Huang
article en
1 citations

Abstract

Our discovery of FN1 as a biomarker for the late-stage diagnosis of NPC will assist in clinical treatment decisions and improve the prognosis of patients.

BMC CancerVol. 25(1)
Sun Yat-sen University (CN), Sun Yat-sen University Cancer Center (CN), Eighth Affiliated Hospital of Sun Yat-sen University
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 24%
Peptidase Inhibition and Analysis
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.